STP-2250

N/A

Report date: 2026/01/27 17:57:33

Base Information

Drug NameSTP-2250

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsYes

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSt Pharm Co Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSt Pharm Co Ltd

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

ATC CodeN/A